시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 혈액뇌장벽(BBB) 기술 시장 보고서(2025년)
Blood Brain Barrier Technologies Global Market Report 2025
상품코드 : 1825637
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,457,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,334,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,211,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

혈액뇌장벽(BBB) 기술 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에 CAGR은 26.2%를 나타낼 것으로 예측되고 50억 9,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 희귀의약품 및 희귀 신경계 질환에 주력하는 경향, 중추신경계(CNS) 관련 부담 증가, 신경계 질환 발생률 증가 및 고령 인구 확대, 바이오마커 탐색 기술 발전, 그리고 견고한 의료 인프라 확충 등에 기인할 수 있습니다. 예측 기간의 주요 동향에는 나노기술 발전, 연구 자금 증가, 중추신경계 장애 치료제 성장, 비침습적 전달 방식 수요 증가, 약물 전달 시스템 개발, 제약사와 바이오테크 기업 간 협력, 그리고 규제 지원 강화가 포함됩니다.

향후 5년간 26.2% 성장이라는 전망치는 이 시장에 대한 이전 추정치 대비 0.7% 소폭 하향 조정된 수치입니다. 이러한 하향 조정은 주로 미국과 타국 간 관세 영향 때문입니다. 무역 긴장은 스위스와 이스라엘에서 개발된 나노입자 약물 전달 시스템 및 체외 혈액뇌장벽(BBB) 모델의 가격 상승을 유발하여 미국 신경학 연구를 저해할 수 있으며, 이는 신경 치료제 개발 지연과 연구개발(R&D) 비용 증가로 이어질 수 있습니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 영향이 더욱 광범위하게 될 것입니다.

혈액 뇌 장벽 시장 시장은 신경계 질환의 증가하는 유병률로 인해 성장할 준비가 되어 있습니다. 이러한 질환은 뇌, 척수, 신경, 근육 등 다양한 컴포넌트를 포함하는 중추 및 말초 신경계 모두에 영향을 미칩니다. 신경계 질환 발생률 증가에 기여하는 요인으로는 고령화 인구, 개선된 진단 방법, 비만 및 좌식 생활 방식과 같은 고위험 요인으로 이어지는 생활 방식 변화 등이 있습니다. 혈액뇌장벽(BBB) 기술은 뇌로의 약물 전달을 개선하는 데 핵심적인 역할을 수행하며, 신경계 질환 치료의 주요 과제 해결과 이러한 질환 관리에 상당한 영향을 미칩니다. 예를 들어, 파킨슨 재단은 2022년 12월 기준 미국 내 파킨슨병 진단 사례가 2021년 대비 50% 급증하여 9만 명에 달했다고 보고했습니다. 이러한 동향은 혈액뇌장벽(BBB) 기술 시장 성장의 원동력을 부각시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Blood-brain barrier (BBB) technologies encompass advanced methods and innovations crafted to explore, manipulate, and traverse the blood-brain barrier. These technologies are geared towards delivering therapeutic agents to the brain while safeguarding the barrier's protective functions, thus aiding in the treatment of neurological disorders.

Key BBB technologies include the bispecific antibody receptor-mediated transcytosis (RMT) approach, the trojan horse approach, methods to increase permeability, passive diffusion, and others. The bispecific antibody receptor-mediated transcytosis (RMT) approach entails utilizing bispecific antibodies capable of binding to targets within the brain and specific receptors on the blood-brain barrier, facilitating their transport into the brain. These technologies find applications in treating conditions such as Alzheimer's disease, epilepsy, Parkinson's disease, multiple sclerosis, Hunter's syndrome, brain cancer, and more. End-users include hospitals, surgical centers, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The blood-brain barrier technologies market research report is one of a series of new reports from The Business Research Company that provides blood-brain barrier technologies market statistics, including blood-brain barrier technologies industry global market size, regional shares, competitors with a blood-brain barrier technologies market share, detailed blood-brain barrier technologies market segments, market trends and opportunities, and any further data you may need to thrive in the blood-brain barrier technologies industry. This blood-brain barrier technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood brain barrier technologies market size has grown exponentially in recent years. It will grow from $1.57 billion in 2024 to $2.01 billion in 2025 at a compound annual growth rate (CAGR) of 27.7%. The growth in the historic period can be attributed to an emphasis on patient-centric drug development, increasing the funds for research, growing awareness about the disease, increasing the prevalence of neurological diseases, and innovation of drugs and delivery devices.

The blood brain barrier technologies market size is expected to see exponential growth in the next few years. It will grow to $5.09 billion in 2029 at a compound annual growth rate (CAGR) of 26.2%. The growth in the forecast period can be attributed to increasing focus on orphan drugs and rare neurological disorders, the growing burden related to CNS, increasing incidence of neurological diseases and augmenting the geriatric population, advancements in biomarker discovery, and robust healthcare infrastructure. Major trends in the forecast period include advancements in nanotechnology, increasing research funding, growth in CNS disorder treatments, rising demand for non-invasive delivery methods, development of novel drug delivery systems, collaboration between pharmaceutical and biotech companies, and increased regulatory support.

The forecast of 26.2% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. neurology research by inflating prices of nanoparticle drug delivery systems and in vitro BBB models developed in Switzerland and Israel, resulting in slowed neurotherapeutic development and higher research and development (R&D) costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The blood-brain barrier technologies market is poised for growth due to the increasing prevalence of neurological diseases. These diseases affect both the central and peripheral nervous systems, including various components such as the brain, spinal cord, nerves, and muscles. Factors contributing to the rising incidence of neurological diseases include an aging population, improved diagnostic methods, and lifestyle changes leading to higher-risk factors such as obesity and sedentary lifestyles. Blood-brain barrier technology plays a crucial role in improving drug delivery to the brain, addressing a major challenge in treating neurological disorders and significantly impacting the management of these diseases. For example, the Parkinson's Foundation reported a steep 50% increase in diagnosed cases of Parkinson's disease in the U.S., reaching 90,000 people in December 2022, compared to 2021. This trend underscores the driving force behind the growth of the blood-brain barrier technologies market.

Leading companies in this market are concentrating on developing innovative, patented technologies to enhance drug delivery specifically to the brain. These advancements represent significant progress in overcoming the hurdles associated with delivering therapeutics to the brain, offering promising solutions for unmet medical needs in neurology. For instance, BioArctic AB was granted a new patent by the US Patent and Trademark Office (USPTO) in November 2022 for technology that enhances the transport of biopharmaceuticals across the blood-brain barrier, part of their Brain Transporter patent portfolio aimed at improving drug effectiveness by bypassing the brain's natural protective barrier.

In October 2024, AbbVie, a U.S.-based biopharmaceutical company, acquired J&J-backed Aliada Therapeutics for $1.4 billion. This acquisition allows AbbVie to expand its neuroscience portfolio by leveraging Aliada's blood-brain barrier (BBB) technology to improve drug delivery for Alzheimer's and other central nervous system (CNS) diseases. Aliada Therapeutics is a U.S.-based biotechnology company specializing in blood-brain barrier technology.

Major companies operating in the blood brain barrier technologies market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Bayer AG, Biogen Inc., Eisai Co. Ltd., Alnylam Pharmaceuticals Inc., JCR Pharma Co. Ltd., Genentech Inc., Denali Therapeutics Inc., Voyager Therapeutics Inc., Fujifilm Cellular Dynamics Inc., Angiochem Inc., Ossianix Inc., ArmaGen Inc., BiOasis Technologies Inc., BioArctic AB

North America was the largest region in the blood brain barrier technologies market in 2024. The regions covered in the blood brain barrier technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood brain barrier technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood brain barrier technologies market consists of revenues earned by entities by providing services such as drug delivery systems and permeability testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood brain barrier technologies market also includes sales of microfluidic devices, biomarkers, chemical permeabilizers, and receptor-mediated transport enhancers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Brain Barrier Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood brain barrier technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for blood brain barrier technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood brain barrier technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Blood Brain Barrier Technologies market Characteristics

3. Blood Brain Barrier Technologies market Trends And Strategies

4. Blood Brain Barrier Technologies market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Blood Brain Barrier Technologies Growth Analysis And Strategic Analysis Framework

6. Blood Brain Barrier Technologies market Segmentation

7. Blood Brain Barrier Technologies market Regional And Country Analysis

8. Asia-Pacific Blood Brain Barrier Technologies market

9. China Blood Brain Barrier Technologies market

10. India Blood Brain Barrier Technologies market

11. Japan Blood Brain Barrier Technologies market

12. Australia Blood Brain Barrier Technologies market

13. Indonesia Blood Brain Barrier Technologies market

14. South Korea Blood Brain Barrier Technologies market

15. Western Europe Blood Brain Barrier Technologies market

16. UK Blood Brain Barrier Technologies market

17. Germany Blood Brain Barrier Technologies market

18. France Blood Brain Barrier Technologies market

19. Italy Blood Brain Barrier Technologies market

20. Spain Blood Brain Barrier Technologies market

21. Eastern Europe Blood Brain Barrier Technologies market

22. Russia Blood Brain Barrier Technologies market

23. North America Blood Brain Barrier Technologies market

24. USA Blood Brain Barrier Technologies market

25. Canada Blood Brain Barrier Technologies market

26. South America Blood Brain Barrier Technologies market

27. Brazil Blood Brain Barrier Technologies market

28. Middle East Blood Brain Barrier Technologies market

29. Africa Blood Brain Barrier Technologies market

30. Blood Brain Barrier Technologies market Competitive Landscape And Company Profiles

31. Blood Brain Barrier Technologies market Other Major And Innovative Companies

32. Global Blood Brain Barrier Technologies market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Brain Barrier Technologies market

34. Recent Developments In The Blood Brain Barrier Technologies market

35. Blood Brain Barrier Technologies market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기